Joint pain affects many people around the world, creating problems with everyday tasks, causing discomfort, and lessening their quality of life. Fortunately, advances in medicine have led to relief for those who suffer from a variety of conditions that result in joint pain, with long-acting injectables being an efficient method of delivery.

At Oakwood Labs, we’re a leader long-acting injectable development, putting our proven methodologies to work in drugs to treat joint pain. Read on to learn more about joint pain drug development and how the Oakwood Labs team can supply exactly what your operations need.

The History and Use of Long-Acting Injectables for Joint Pain Pharmaceuticals

Long-acting injectables were created in the 1950s to aid patients suffering from mental health conditions such as schizophrenia. As procedures evolved and new developments arose in the ensuing decades, the treatment of other conditions, including those centered more on the total body rather than just the mind, began to emerge. This includes using long-acting injectables to administer drugs for treating joint pain in knees, elbows, shoulders, and other problem areas.

Some of the common conditions that are suited for long-acting injectable medication distribution include:

• Osteoarthritis
• Rheumatoid arthritis
• Bursitis
• Tendonitis
• Psoriatic arthritis

Meanwhile, there are a range of medication types that may be distributed. These can include osteoarthritis pharmaceuticals, rheumatoid arthritis pharmaceuticals, and other forms, with specific injections containing:

• Corticosteroids
• Hyaluronic acid
• Platelet-rich plasma
• Additional formulations

Key Benefits of Long-Acting Pharmaceutical Drugs to Treat Joint Pain

Long-acting injectables, sometimes referred to as extended-release drugs or “ER drugs,” help to provide ongoing pain relief to patients who are suffering from an array of conditions. The result is a better quality of life, better pain management, increased mobility, and fewer dosages. Other benefits of these pharmaceuticals for treating joint pain include:

• Fewer side effects – Using long-acting injectable pharmaceuticals to treat joint pain can result in fewer side effects for patients because they will receive less frequent dosages than with immediate-release approaches. The reduced side effects are also facilitated by patients receiving lower peak concentrations of the given drug.
• Improved patient compliance – Since long-acting joint pain pharmaceuticals necessitate fewer doses, patients who take them are more likely to follow the plan put in place by their healthcare professionals. This results in improved pain management and happier patients.
• Reduced pain level fluctuations – Patients who take immediate-release drugs may notice a fluctuation in pain levels for their joint issues, but long-acting injectables lessen this experience, offering a more stable and controlled release that manages pain.

Our Abilities in Joint Pain Drug Development

The Oakwood Labs team has been proud to tackle projects for osteoarthritis drug development and rheumatoid arthritis drug development, providing long-acting injectables with a release duration of three months.

Our team specializes in developing pharmaceuticals that treat joint pain and can assist with developing formulations, scaling up the manufacturing process, and manufacturing clinical and commercial quantities under GMPs.

We find that long-acting injectables are ideal for use with pharmaceuticals for treating joint pain because joint pain often emanates from a specific bodily area and high concentrations of a drug can be administered without resulting in systemic exposure. This, and the potential for disease-modifying results, are yet more benefits to the LAI approach.

Our Work with LAI Formulations

In terms of our work, Oakwood has developed a 3-month LAI formulation of meloxicam. Meloxicam is one of the more potent NSAIDs, which enables targeted release in the intra-articular space, and thus avoids the systemic side effects of NSAIDs. Due to the high potency of meloxicam, a smaller injection volume is possible.

Challenges We Have Faced

One of the current barriers to entering this particular space is the difficulty of developing the proper formulation. Microspheres are preferable to gels that solidify after injection due to the mechanics of the joint and intra-articular space. Microspheres should be greater than 20 microns to avoid macrophages attacking them. Work with our team of LAI experts to develop the right formulation.

Partner with Us on Drugs to Treat Joint Pain

Oakwood Labs is actively looking to partner with interested organizations for co-development of programs such as those focused on treating joint pain. Be sure to visit our partnership page for more information on our approach and all areas we focus on. We would love to work with you to bring new drugs to market.

Have Questions About Pharmaceuticals to Treat Joint Pain? Contact Us

Reach out to the team at Oakwood Labs today and we can discuss our methodologies, facilities, previous projects, and more. We look forward to hearing from you.

The pharmaceutical industry encompasses a vast range of key facts and significant data that can be beneficial to individuals and companies in the field. That’s why our team has compiled a list of 35 statistics for your review, so you can learn more about this thriving sector.

Statistics About the Pharmaceutical Market

• The total global pharmaceutical market in 2023 was estimated at around $1.6 trillion (Statistica)
• Compared to 2022, the total global pharmaceutical market increased by over 100 billion dollars in 2023 (Statistica)
• The United States accounts for nearly 40% of the world’s pharmaceutical market (National Library of Medicine)
• As of 2023, the top 5 largest pharmaceutical companies were Eli Lilly ($578.3B), Novo Nordisk ($452.8B), Johnson & Johnson ($377.7B), Merck ($263.9B), and AbbVie ($261.2B) (Visual Capitalist)
• Approximately $60 billion is spent collectively by the top 20 pharmaceutical companies each year for drug development (McKinsey & Company)
• The United States accounts for roughly 50% of global pharmaceutical sales revenue (PharmaNewsIntelligence)
• The pharmaceutical market in the United States is expected to surpass $1 trillion by the year 2030 (American Pharmaceutical Review)
• The biopharmaceutical market is expected to reach nearly $517 billion in 2024, and reach up to almost $762 billion by 2029 (Modor Intelligence)
• From 2024 to 2028, the pharmaceutical market is projected to experience an increased annual growth rate of 5.96% (Statistica)
• By 2027, the total global spending on medicine is projected to reach $1.92 trillion (Statistica)
• Currently, the United States is looking for an increased demand for personalized medicine and more targeted therapies (Statistica)

A Career in the Pharmaceutical Industry: Noteworthy Statistics

• 56.8% of pharmacists in the United States are women and 43.2% of pharmacists are men (Zippia)
• Approximately 1.3 million people are employed in the pharmaceutical industry in the United States (U.S. Bureau of Labor Statistics)
• The average age of a pharmacist is 41 years old (Zippia)
• 91% of graduated pharmacists are known to work in the private sector (NIH)
• The average salary of a pharmacist is $118,968 as of 2024 (Zippia)
• The highest paying state for pharmacists is California, where the average yearly salary is $161,597 (Zippia)
• For every dollar that a man makes as a pharmacist, a woman makes approximately 98¢ (Zippia)
• The employment for pharmacists is expected to grow by 3% from 2022 to 2032 (U.S. Bureau of Labor Statistics)
• Over the decade, there is said to be 13,400 openings for pharmacists projected each year (U.S. Bureau of Labor Statistics)

Statistics on Popular Prescription Drugs

• According to the Centers for Medicare & Medicaid Services (CMS), out-of-pocket drug spending is projected to peak in 2023 at $52.5 billion (Peterson-KFF)
• As of July of 2023, 25% of adults who take prescription drugs report difficulty in affording their medication (Peterson-KFF)
• There are more than 32,000 generic drugs that are approved by the FDA as of 2022 (FDA)
• In the United States, 91% of prescriptions are filled as generic drugs (FDA)
• Nationwide, the total spending on prescription drugs increased from $30 billion in 1980 to $335 billion in 2018 (Congressional Budget Office)
• Though the top 10% of drugs by price account for less than 1% of all prescriptions, they make up 15% of the retail spending and anywhere from 20% to 25% of the nonretail spending (ASPE)
• In 2020, around 6.3 billion prescriptions were dispensed in the United States (Statistica)

Contact Oakwood Labs for More Information

Oakwood Labs is a global provider of sustained-release pharmaceuticals and other medical services. Please contact our team of experts today for more information about all we can provide, as we look forward to answering any inquiries you have.

There are many routes of drug delivery, including oral, intravenous, intramuscular, transdermal, inhalation, and subcutaneous. The choice of route will depend on the desired onset of action, the medication’s properties, and patient preferences.

Subcutaneous, or subQ, drugs are delivered below the skin into the layer of tissue beneath the dermis and epidermis. They are typically administered using a needle, which allows the drug to be absorbed into the bloodstream and distributed throughout the body. Read on to learn about key facets of subcutaneous drug delivery and development and how the Oakwood Labs team can assist you with the process.

Understanding the Benefits of Subcutaneous Delivery of Drugs

The subcutaneous delivery of drugs works to balance effectiveness, convenience, and patient comfort while providing therapeutic relief. The location of an injection is usually preferred on the thigh, stomach (around the belly button), or the upper outer arm. The injection device often depends on the dose, ergonomic design for ease of use, and other factors, but can include syringes with attached needles, prefilled syringes, autoinjectors, and pen injectors. Drugs that are administered subcutaneously include insulin for diabetes, growth hormones, anticoagulants, vaccines, and certain types of chemotherapy drugs.

The benefits of subcutaneous drug delivery include:

• Fast absorption – Depending on the drug being administered, it is possible for subcutaneous drugs to absorb rapidly into the bloodstream because they bypass the digestive system. This leads to a quicker onset of action, making them ideal for anything that requires quick effects or emergency treatments.
• User-friendly application – Did you know that some EpiPens use subcutaneous delivery? When not administered through an intramuscular route, EpiPens can use subcutaneous drug delivery in the upper thigh to treat allergic reactions, which means they are able to be used by patients of almost any age.
• Improved bioavailability – Certain drugs have poor oral bioavailability due to degradation in the digestive tract or metabolism in the liver. Subcutaneous delivery of a drug improves its bioavailability because it releases the drug directly into the circulation of the system.
• Reduced variability in absorption – Oral medications can be impacted by food intake and gastrointestinal factors. Subcutaneous drug delivery provides more consistent and reliable absorption, which offers more consistent results.
• Versatility – Subcutaneous delivery is ideal because it is typically less painful and offers a larger range of possible injection sites when compared to intramuscular injections.
• Sustained-release design – There are specific drugs that can be delivered subcutaneously over an extended period of time. This results in more stable drug levels in the bloodstream, which improves patient compliance by removing the need for frequent dosing.

Using Sustained-Release Subcutaneous Drug Delivery

Using sustained-release subcutaneous drugs provides a controlled and prolonged release of medicine into the bloodstream. This results in consistent therapeutic effects for patients and reduces the need for frequent visits. Additionally, it reduces any side effects because the formulations are created to consistently deliver the drug, therefore minimizing peak drug concentrations. When starting the development of sustained-release, subcutaneous-delivery drugs, there are many different factors to consider, including drug solubility, release kinetics, biodegradability, and compatibility with the injection method.

Once it’s time to formulate the subcutaneous drug that uses sustained-release technology, it is essential to consider the matrix systems, microsphere or nanoparticle formulations, and implantable devices. If you need assistance with your subcutaneous drug development, the dedicated team at Oakwood Labs is ready to get to work on your project.

Choose Oakwood Labs for Developing Subcutaneous-Delivery Drugs

Since 1997, Oakwood Labs has been operating a fully compliant, aseptic cGMP manufacturing facility that is designed to manufacture sustained-release injectable pharmaceutical products, and we are adept at subcutaneous drug development.

Our team is committed to creating pharmaceutical products that provide enhanced therapeutic benefits to patients and returns to our pharmaceutical partners, using our Chroniject™, a patented polymer-based injectable microsphere system for drug delivery. Be sure to use our team’s expertise and our cutting-edge facility for your next project.

Contact Us About Subcutaneous Drug Development

For more information on our abilities in subcutaneous drug development, please contact us today. We’re ready to assist you.

Related Blog Posts

• The Role of Small Molecules in Pharmaceutical Development
• Our Work in Developing Sterile Injectables
• The Many Uses and Benefits of Intra-Articular Injections

An intra-articular injection is a treatment that provides localized, targeted relief to patients with joint pain. These injections are the preferred method of treatment for certain patients because they are fast-acting, offer reduced side effects, and, of course, provide targeted pain relief.

Learn about the background of intra-articular injections, the means of treatment, and what it’s like to work with Oakwood Labs to develop them for your operations.

The History of Intra-Articular Injections

Intra-articular injections were the product of a few different methods of pre-existing treatments and have evolved alongside technology and discoveries within the medical space to become what they are today. Part of the origin for intra-articular injections derived from joint aspiration, where healthcare professionals would remove fluid from the joint space and assess the fluid for any inflammatory conditions or infections.

Another milestone that helped in the development of intra-articular injections was the introduction of corticosteroids in injections. These substances have powerful anti-inflammatory properties and were found to be effective in the treatment of joint inflammation. Therefore, it made sense to test them in intra-articular injections, which proved to be a success.

Additionally, advancements in imaging techniques like ultrasounds and fluoroscopy helped increase the accuracy and precision of intra-articular injections, as these tools can help guide the needle during injection.

As ongoing research and innovation occurred, more discoveries about intra-articular injections were made. These advancements continued to encourage the production of the best treatments possible, and clinical guidelines and standardizations ensured proper administration, patient safety, and optimal outcomes.

Today, intra-articular injections are used widely in rheumatology, orthopedics, and sports medicine to provide relief to patients. Typically, these patients have osteoarthritis, rheumatoid arthritis, gout, tendinitis, bursitis, joint effusion, or post-operative swelling.

Medications Utilized in Intra-Articular Injections

Depending on their needs and previous medical history, candidates for intra-articular injections are typically treated with the following:

• Corticosteroids – As mentioned above, corticosteroids like cortisone can be extremely therapeutic for patients who have joint pain. Corticosteroids are very powerful anti-inflammatory medications that alleviate joint pain by reducing swelling and inflammation.
• Hyaluronic acid – Hyaluronic acid is a substance that is naturally found in joint fluid and can be injected to provide lubrication and cushioning in joints. It is often used to treat conditions like osteoarthritis.
• Platelet-rich plasma – PRP is used to promote healing and reduce pain and inflammation in patients. It is derived from the patient’s blood and is rich in both platelets and growth factors.

Let Our Team Help

If you are looking for a partner who can assist with manufacturing intra-articular injections, Oakwood Labs is ready to step in. We use a patented technology called Chroniject^TM to help you treat patients through parenteral drug administration, the umbrella term that refers to delivering medications and other therapeutic benefits through routes other than the digestive tract. Intra-articular delivery is one of the ways to do this.

The Oakwood Labs team operates in an FDA-approved, aseptic facility and is committed to adhering to Good Manufacturing Practices to ensure product safety and quality. From material sourcing and formulation to sterilization, filling, packing, and beyond, the Oakwood Labs team is there with you every step of the way in the manufacturing process. We have been manufacturing pharmaceutical treatments since 1997, and look forward to continuing to innovate into the future.

Contact Oakwood Labs for Intra-Articular Injection Manufacturing

If you are ready to provide therapeutic relief to patients with joint pain through intra-articular injection manufacturing, be sure to contact us today.

We look forward to working with you on your next project.

Animal pharmaceuticals are treatments that are designed to prevent, diagnose, or treat disease in animals to promote overall well-being. This goal applies to a variety of animals, including livestock, poultry, and even wildlife.

The world of animal health pharmaceutical development has also played a significant role in the fast-growing and evolving world of pet pharmaceuticals. Read on to learn about all of these aspects and how Oakwood Labs can partner with your facility for effective pharmaceutical development.

Our Process for Animal Health Drug Development

The demand for animal health pharmaceuticals is rising due to population growth, urbanization, changes in dietary habits, increased awareness of animal welfare, and more. To keep up with this demand, the industry continues to shift via research, new technology, and regulations that address the evolving needs of animals.

Discover the advantages of animal health pharmaceutical development:

• Improved animal health and welfare – Veterinary pharmaceuticals are a way to provide effective treatments for infections and chronic conditions. Just like humans, pets and livestock need treatments when they fall ill or have an ongoing condition, and these treatments make symptoms much more tolerable for the animal and its owner.
• Disease prevention and control – Injectables and other preventative medicines help control the spread of infectious diseases among animals, which reduces the risk of outbreak and transmission to other animals and even humans in some cases.
• Companion animal care – Pharmaceuticals for pets address varied health concerns, including pain management, behavioral issues, and chronic diseases. Having medicines that treat these problems gives owners a way to provide optimal care for their pet, fostering stronger bonds.
• Food safety and security – Pharmaceuticals are critical for maintaining the health of livestock and poultry, which leads to safer and higher-quality animal-derived food products. This results in a better food supply chain by reducing the risk of foodborne illnesses.

FAQs About Animal Health Pharmaceutical Development

To help you get a better understanding of animal health pharmaceutical development, we listed some FAQs that might clear up some confusion on the subject.

What is the general process for animal health drug development?

Animal health pharmaceutical development follows a similar process to that of drug manufacturing for humans. The stages include research and discovery, preclinical testing, regulatory approval, clinical trials, manufacturing, quality control, and post-market surveillance. The FDA oversees the approval and safety of animal health pharmaceuticals, ensuring that they meet the standards for efficacy.

What are some recent developments in animal health pharmaceuticals?

Discoveries in the area of animal health pharmaceutical development are being made constantly. Some of the more notable ones made recently include the development of novel drug technologies, the discovery of new treatment modalities, and the use of genomics and biotechnology to develop customized medicine for animals.

How do long-acting injectables benefit animal health drug development?

Long-acting injectables offer sustained therapeutic effects through a single injection, which is convenient for both animals and their caregivers. This method of administration minimizes stress for animals and improves treatment adherence, which leads to better outcomes for a variety of health conditions.

Work with Oakwood Labs for Animal Health Drug Development

At Oakwood Labs, we have a full-service cGMP manufacturing facility that hosts a range of contract manufacturing services. We produce commercial products for use by both humans and animals, and our batch sizes range from 1,000 to 20,000 vials per batch. In our GMP manufacturing facility, we are able to accomplish the following:

• In-house QC microbiology and QC chemistry
• Raw material dispensing and weighing
• Non-aseptic formulation
• Equipment preparation and staging
• Compact and portable equipment train
• Aseptic formulation
• Aseptic filling
• Aseptic lyophilization
• Vial capping
• Inspecting, labeling, and packaging
• Shipping and receiving

In addition to these capabilities, we also bring more than 20 years of experience to your project. We would love to be your partner in animal health drug development.

Contact Us Today About Animal Health Pharmaceutical Drug Development

When you are ready to get started with animal health pharmaceutical drug development, we are ready to assist.

Be sure to contact us today with any questions you might have.

Best known for their versatile role in a vast array of chemical applications, organic solvents play a crucial role in numerous sectors, including the medical industry.

To gain a better understanding of how these solvents can contribute to pharmaceutical practices and manufacturing techniques for drug delivery, review our complete guide for more information.

An Overview of Organic Solvents

As industry experts are aware, organic solvents are solvents that contain carbon atoms capable of either dispersing or dissolving one or more substances. Due to their chemical makeup, these solvents can be utilized in a variety of industries, such as textiles, cleaning, agriculture, and pharmaceuticals.

Additionally, common characteristics and properties of suitable organic solvents include the following:

• High volatility
• Acid-based properties
• Low boiling point
• Suitable density

As opposed to some inorganic solvents, organic solvents can also be described as combustible and extremely flammable. That’s why we advise that those looking to work with organic solvents in long-acting injectables, or processes such as spinning and dyeing textiles, ensure that they are handling these carbon-based solvents with the utmost care.

The Role of Organic Solvents in Long-Acting Injectables

Organic solvents in pharmaceuticals, such as long-lasting injectables, can contribute to an expansive array of roles throughout the drug delivery process, such as the following:

• Dissolving drugs at high concentrations – Organic solvents can be utilized to dissolve drugs, such as biologics, that otherwise have a higher concentration and a lower aqueous solubility. That way, long-acting injectables can be administered at the appropriate viscosity and form drug depots under the skin’s surface.

• Forming drug depots – Drug depots, or depot injections, are longer-duration drugs that result in a slow absorption into the bloodstream. Though organic solvents can contribute to the formation of these drug depots, the administration of the drug into your muscle is best when using a depot.

• Determining the rate of release – Once the drug depot has formed, organic solvents decelerate the rate of their delivery, resulting in a more gradual, sustainable release and absorption of the medication over time.

A Look at Organic Solvents in Pharmaceuticals: Their Industry Uses and Beyond

Along with their inherent contribution to the production of long-lasting injectables, organic solvents in pharmaceuticals play many key roles in the total industry. Beyond mainly being utilized as reaction media, organic solvents are used in the following processes:

• The purification of synthesis products
• Excipients, such as coloring agents, preservatives, and fillers
• The bioavailability of orally administered protein-active sites
• Semiempirical models of meditated solubility
• Antisolvent crystallization techniques in pharmaceutics

Additionally, organic solvents can even be used in water-based cleaning solutions. This is because they are capable of penetrating oily soil deposits while also dissolving in water.

FAQs About Organic Solvents, Their Capabilities, and More

What are the most common organic solvents used in pharmaceutical manufacturing?

The most common applications when working with organic solvents in pharmaceuticals include the following:

What safety precautions should be taken when working with organic solvents in pharmaceuticals?

As stated previously, organic solvents can be extremely flammable and volatile, so handling them with care is essential. With that in mind, here are some stringent safety regulations you should abide by during the manufacturing process:

• Gloves and safety glasses should be worn when handling the materials
• A fume-hood is required when pouring out organic solvents
• Spill kits and eyewash stations should be readily available in the workspace
• Flammable liquids, such as bleach, peroxides, and acids, should be stored away from organic solvents

Can organic solvents be reused or recycled?

Yes, organic solvents can be recycled easily and reused in syntheses. This includes collected solvents that are separated by distillation and have different boiling points.

Contact Oakwood Labs for More Information

As your trusted resource for sustained-release injectables and other services, Oakwood Labs is well-equipped with the necessary tools to satisfy your application needs.

For more information about organic solvents in pharmaceuticals, long-acting injectables, and more, please reach out to our team today. We look forward to assisting you.

Long-acting injectables are favored in the medical field due to their effectiveness and convenience, as their injection methodology allows for the gradual release of medication into the bloodstream. In post-operative care, the alleviation of pain is vital not only for recovery, but for the comfort of the patient. With the help of long-acting injectable drugs for post-surgical pain management, patients can experience a more effective recovery.

The History of Long-Acting Injectables

Long-acting injectable drugs were first introduced as a treatment for people with chronic schizophrenia. These long-acting injectable antipsychotic drugs were created as an effort to solve the issue of poor adherence to oral medications. Some notable points in the history of long-acting injectables include the following:

• 1950s – 1970s – Long-acting injectables were created to help manage conditions such as schizophrenia. In 1952, chlorpromazine (CPZ) was developed in Paris, offering an effectiveness greater than that of older drugs on the market. Then in 1966, thanks to G.R. Daniels, a medical director at the time, the first long-acting injectable was created. This first injectable was AP fluphenazine enanthate, with fluphenazine decanoate being created just eighteen months later.
• 1980s – 1990s – During this time, long-acting injectables for second-generation antipsychotics were introduced. Between 1988 and 1992, Risperidone was first developed by Janssen-Cilag. Its purpose was to treat behavior issues in children and adolescents.
• 2000s – present – Long-acting injectables have come a long way since their creation. With their medication methodology, they can provide better adherence to timelines, facilitate proper dosing, and free patients from having to take oral medications every day. With continuing research on long-acting injectables, we are seeing uses in areas such as contraception, chronic and acute pain, antiretroviral therapy, and more.

The Role of Long-Acting Injectables for Post-Surgical Pain Management

A key factor of post-surgical work is minimizing patient pain, giving them the time they need to heal. With the use of extended-release drugs for post-surgical pain management, doctors are better able to effectively manage pain for their patients and promote an expedited recovery process.

Types of Injectables Used for Post-Surgery

NSAIDs, or nonsteroidal anti-inflammatory drugs, are medications that reduce fever, pain, and inflammation. Looking at postoperative care, NSAIDs help in mitigating pain, minimizing the reliance on opioids, and fostering a healing environment. You may be familiar with some over-the-counter NSAIDs such as ibuprofen or aspirin.

NSAIDs are known to prevent blood from clotting, which can definitely be beneficial in post-surgery situations. In cases such as orthopedic procedures that involve prolonged immobility, there is an increased risk of blood clot formation. NSAIDs help prevent that blood clotting, specifically in the veins.

Some common NSAIDs that have been used as long-acting injectables for post-surgery pain management include:

• Toradol (Ketorolac) – This NSAID is used to relive pain and is commonly available in injection or tablet form. The injections work about thirty minutes after administration and the effects can last up to six hours. Often prescribed for post-surgery pain, it typically is distributed as a one-time injection. However, some people may receive a shot every six hours. This will depend on factors such as body weight, age, drug interactions, and others.
• Diclofenac sodium – This medication is another NSAID used to treat adults with mild to moderate pain. It can be used for osteoarthritis, low back pain and for post-operative patients. Similar to Toradol, the effects may start to work immediately after the injection.
• Caldor – This ibuprofen injection works by reducing fever and treating pain in the body. It helps manage pain as an adjunct to opioid analgesics.
• Ketoprofen – Ketoprofen can help with acute and chronic pain, both for the traumatic and rheumatic origin. Additionally, it can help alleviate postoperative pain, specifically in the orthopedic field. While ketoprofen is offered as an injectable, that is not the intended use for humans. There is an oral tablet for humans, only available with a doctor’s prescription. The injectable form is actually intended for animals, such as horses. In horses, it’s used for musculoskeletal pain or inflammation, abdominal pain, and other inflammatory conditions. It can also be used effectively for cattle, goats, sheep, and pigs.

The Capabilities of Oakwood Labs

At Oakwood Labs, we are a leading developer of sustained-release pharmaceuticals and have over 20 years of experience in drug encapsulation. We are here to offer support throughout the development of different types of long-acting injectables.

Our facilities can provide the following to help you achieve your project goals:

• GMP manufacturing (commercial and aseptic)
• Pre-formulation development
• Phase I, II, and III clinical trial manufacturing
• Scaling formulation
• ICH compliant stability tests
• Feasibility studies
• Toxicology batch manufacturing

Contact Us to Learn More

With our history of compliance and commitment to quality, we continue to be a leader in injectable pharmaceutical development. If you’re wanting to learn more about injectable development or our other capabilities, contact us today.

Knee pain is a common issue for adults because it is caused by general stress from normal daily activities. In fact, around 25% of U.S. adults experience knee pain, and many of them require treatment to make day-to-day activities easier.

Long-acting injectables are able to target specific anatomical areas like eyes, ears, knees, and other spots to relieve pain and reduce systemic exposure. This means they are capable of providing a means of comfort for patients experiencing problems like osteoarthritis, rheumatoid arthritis, bursitis, or tendonitis. Learn more about the benefits of extended-release drugs for knee pain and how you can help patients by manufacturing them.

Benefits of Using Extended-Release Drugs for Knee Pain

Extended-release drugs and long-acting injectables for knee pain are designed to release the active ingredient over time. These medications encourage the maintenance of the therapeutic levels in the body for an extended time period and provide prolonged pain relief. The outcome of prolonged pain relief is less frequent dosages and happier patients.

Other benefits of using these types of medication include:

• Reduced side effects – Extended-release drugs encourage lower overall doses when compared to the immediate-release competition. This can lead to fewer side effects, as the patient will be exposed to a lower peak concentration of the drug.
• Improved patient adherence – Since these types of drugs require less frequent doses, patients are more likely to adhere to their prescribed regimen. This can lead to better pain management outcomes, making them the go-to choice for more patients.
• Minimized fluctuations in pain levels – When patients are given immediate-release formulations they may experience highs and lows from the drug concentration that leave them with fluctuations in the extremity of their knee pain. Using extended-release medications for knee pain limits this issue by providing a consistent and controlled release.

Types of Extended-Release Drugs for Knee Pain

There are currently two main types of extended-release injectable drugs for knee pain. The type that is administered will depend on the patient’s problem, pre-existing health conditions, and more.

Corticosteroid Injections

Corticosteroid injections reduce pain and inflammation in the knee joint, thanks to their powerful anti-inflammatory agents. These synthetic drugs mimic the effects of natural hormones produced by adrenal glands. The relief is often found quickly, with many patients experiencing reduced pain in just a few days. The relief should last around three to four months, depending on the patient and the severity of their condition.

A prominent example of a corticosteroid long-acting injectable for knee pain is inserting Triamcinolone LAI in the knee. Another common type is ZILRETTA®.

Hyaluronic Acid Injections

Another type of long-acting injectable drug for knee pain is hyaluronic acid injections. Known for their ability to replenish knee lining and reduce friction on the joints, hyaluronic acid injections are an extremely effective treatment for those fighting osteoarthritis. These injections also protect the cartilage and bone from further damage, relieving pain effectively. While they may not have the longevity of a typical long-acting injectable drug for knee pain, they will provide patient relief for between two and six months.

Hyaluronic knee injections currently on the market include Durolane, Euflexxa, Hyalgan, Monovisc, and more.

Using Best Practices When Manufacturing Long-Acting Injectables for Knee Pain

Adhering to best practices when producing long-acting injectable drugs for knee pain is essential, and it’s something the team at Oakwood Labs is committed to. Doing so assures your patients that the solution was created using rigorous processes and that the medication is safe.

Let’s discuss some of the best practices for creating extended-release drugs for knee pain and how Oakwood Labs can provide.

• Conduct clinical research and development – The process starts with conducting pre-clinical studies to assess feasibility, safety, and efficacy. Then, it is time to study the population to create the intended patient demographic, as well as execute clinical trials to ensure that the solution is relevant to the problem and population.
• Create optimal formula – The next step is to research and develop a formulation that will provide sustained and effective pain relief without complications or introducing new side effects. Be sure to check this over time and ensure that the extended-release drug for knee pain will continue to provide the most benefits to the patient.
• Determine dosing and administration – Based on clinical research results, you will want to determine an appropriate dosage and administration schedule. Then, create clear and concise instructions for proper administration for patient safety and reduced risk.
• Assess safety – Once you develop the proper instructions for administering the long-acting injectable for knee pain, it is important to conduct comprehensive safety assessments that define adverse effects, drug interactions, and any risks. Then, be sure to monitor unexpected side effects during post-marketing surveillance.
• Provide education and training – Collect comprehensive educational materials that healthcare professionals and patients can look at to ensure the best understanding of the long-acting injectable for knee pain as well as any side effects.
• Adhere to ethics – Ethics are a priority in pharmaceutical manufacturing, covering everything from reporting results to ensuring equal access. Be sure to adhere to ethical standards in all aspects of development.
• Choose a GMP manufacturer – Oakwood Labs operates in an FDA-approved cGMP manufacturing facility that is capable of conducting Phase I, II, and III clinical materials, delivering commercial products, and more. We also have decades of industry experience, making us the ideal destination for manufacturing long-acting injectables for knee pain. As your partner, we can offer short lead times, robust systems, CMC development capabilities, and so much more.

Contact Us to Learn More

If you are interested in manufacturing extended-release drugs for knee pain, Oakwood Labs would be happy to partner with you.

Contact us today to get started.